Ireland
Tuberculosis profile
Population  2012 4.6 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.018 (0.018–0.018) 0.39 (0.38–0.39)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.01 (0.01–0.02)
Prevalence  (includes HIV+TB) 0.5 (0.18–0.97) 11 (4–21)
Incidence  (includes HIV+TB) 0.39 (0.34–0.44) 8.6 (7.5–9.7)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.09 (0.08–0.1)
Case detection, all forms (%) 87 (77–99)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 77 (31) Relapse    
Smear-negative 32 (13) Treatment after failure    
Smear-unknown / not done 65 (26) Treatment after default    
Extrapulmonary 75 (30) Other 25 (100)
Other 1 (<1)      
Total new 250   Total retreatment 25  
           
Other (history unknown) 91        
Total new and relapse 250   Total cases notified 366  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.0 1.2 1.6
Age < 15 2 3 3
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 64   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 59  
Retreatment 54  
TB/HIV 2012 Number (%)
TB patients with known HIV status 97 (27)
HIV-positive TB patients 14 (14)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.1 (0.13–3.8) 0 (0–20)
MDR-TB cases among notified pulmonary
TB cases
2 (0–7) 0 (0–5)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 190 (97%) 17 (68%) 266
Laboratory-confirmed MDR-TB cases 2 0 5
Patients started on MDR-TB treatment     5
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-23 Data: www.who.int/tb/data